1. Expanded Differentiation Capability of Human Wharton's Jelly Stem Cells Toward Pluripotency: A Systematic Review
- Author
-
Ricardo Fernández-Valadés, Indalecio Sánchez-Montesinos, Rena N. D'Souza, Fernando Campos, Jesús Chato-Astrain, Miguel Alaminos, MA Martín-Piedra, Ingrid Garzón, and Antonio Campos
- Subjects
Pluripotent Stem Cells ,Homeobox protein NANOG ,0206 medical engineering ,Biomedical Engineering ,Bioengineering ,02 engineering and technology ,Biology ,Regenerative Medicine ,Biochemistry ,Regenerative medicine ,Biomaterials ,SOX2 ,Wharton's jelly ,Humans ,Cell Lineage ,Stem Cells ,Mesenchymal stem cell ,Cell Differentiation ,Mesenchymal Stem Cells ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Embryonic stem cell ,Cell biology ,Stem cell ,0210 nano-technology ,Multipotentiality - Abstract
Human Wharton's jelly stem cells (HWJSC) can be efficiently isolated from the umbilical cord, and numerous reports have demonstrated that these cells can differentiate into several cell lineages. This fact, coupled with the high proliferation potential of HWJSC, makes them a promising source of stem cells for use in tissue engineering and regenerative medicine. However, their real potentiality has not been established to date. In the present study, we carried out a systematic review to determine the multilineage differentiation potential of HWJSC. After a systematic literature search, we selected 32 publications focused on the differentiation potential of these cells. Analysis of these studies showed that HWJSC display expanded differentiation potential toward some cell types corresponding to all three embryonic cell layers (ectodermal, mesodermal, and endodermal), which is consistent with their constitutive expression of key pluripotency markers such as OCT4, SOX2, and NANOG, and the embryonic marker SSEA4. We conclude that HWJSC can be considered cells in an intermediate state between multipotentiality and pluripotentiality, since their proliferation capability is not unlimited and differentiation to all cell types has not been demonstrated thus far. These findings support the clinical use of HWJSC for the treatment of diseases affecting not only mesoderm-type tissues but also other cell lineages. Impact statement Human Wharton's jelly stem cells (HWJSC) are mesenchymal stem cells that are easy to isolate and handle, and that readily proliferate. Their wide range of differentiation capabilities supports the view that these cells can be considered pluripotent. Accordingly, HWJSC are one of the most promising cell sources for clinical applications in advanced therapies.
- Published
- 2020